Doripenem is a broad-spectrum carbapenem antibiotic used to treat complicated intra-abdominal and urinary tract infections. It is grouped under the following drug class(es): Beta-lactams and Carbapenems. Its therapeutic use is listed as anti-infectives, antibacterials and antibiotics. The directory classifies it as a discontinued API with a semi-synthetic source/manufacturing origin. Other names for this substance include Doribax and Finibax. Its PubChem CID is 73303.
Doripenem
| CAS No | 148016-81-3 |
|---|---|
| Molecular Formula | C15H24N4O6S2 |
| Molecular Weight | 420.5 g/mol |
| Synonyms | (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Doripenem is a broad-spectrum carbapenem antibiotic used to treat complicated intra-abdominal and urinary tract infections. It is grouped under the following drug class(es): Beta-lactams and Carbapenems.
The listed CAS number is 148016-81-3.
The listed molecular formula is C15H24N4O6S2.
The listed molecular weight is 420.5 g/mol.
(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid.
The source lists Doribax and Finibax.